Ralliant Corporation (NYSE:RAL) Receives Average Recommendation of “Moderate Buy” from Analysts

Ralliant Corporation (NYSE:RAL) has received a consensus recommendation of “Moderate Buy” from the ten analysts that are currently covering the stock, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price target among brokers that have covered the stock in the last year is $58.00.

A number of analysts have recently commented on RAL shares. Truist Financial assumed coverage on Ralliant in a research report on Friday, December 12th. They issued a “buy” rating and a $62.00 price objective for the company. Barclays boosted their price target on shares of Ralliant from $59.00 to $60.00 and gave the stock an “overweight” rating in a report on Wednesday, January 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of Ralliant in a research report on Monday, December 29th. Citigroup raised shares of Ralliant from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $53.00 to $61.00 in a research note on Monday, December 8th. Finally, Oppenheimer raised their price target on shares of Ralliant from $55.00 to $60.00 and gave the company an “outperform” rating in a research note on Monday, December 15th.

Ralliant Trading Down 1.8%

Shares of Ralliant stock opened at $52.86 on Friday. Ralliant has a fifty-two week low of $40.70 and a fifty-two week high of $55.25. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.03 and a current ratio of 1.49. The company has a market cap of $5.96 billion and a P/E ratio of 41.62. The firm has a 50-day simple moving average of $51.52 and a two-hundred day simple moving average of $46.69.

Ralliant (NYSE:RAL) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.58 by $0.02. The business had revenue of $529.10 million during the quarter, compared to analysts’ expectations of $519.14 million. Ralliant has set its Q4 2025 guidance at 0.620-0.680 EPS.

Ralliant Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be given a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Monday, March 9th. Ralliant’s dividend payout ratio (DPR) is 15.75%.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Westfuller Advisors LLC acquired a new stake in Ralliant during the 3rd quarter worth $26,000. V Square Quantitative Management LLC acquired a new position in Ralliant during the fourth quarter worth about $26,000. Palisade Asset Management LLC purchased a new stake in Ralliant during the 3rd quarter valued at about $26,000. Manchester Capital Management LLC acquired a new stake in Ralliant in the 2nd quarter valued at about $29,000. Finally, UMB Bank n.a. acquired a new stake in Ralliant in the 3rd quarter valued at about $29,000.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.